Skip to main content
Log in

Abnormal vitamin D metabolism in patients with cirrhosis

  • Original Articles
  • Published:
The American Journal of Digestive Diseases Aims and scope Submit manuscript

Abstract

To assess the role of hepatic function and alcohol on vitamin D metabolism, serum 25-hydroxyvitamin D (25-OHD) levels were measured in 20 healthy nonalcoholic control subjects, 31 “inactive” cirrhotics whose alcoholism was in remission, 8 alcoholic cirrhotics, and 15 alcoholics with normal liver function. Cirrhosis, but not alcoholism, was associated with low serum 25-OHD levels. The aminopyrine breath test (ABT) was performed because aminopyrine, like vitamin D3, is metabolized by hepatic microsomes; the ABT correlated highly (r-0.74,P<0.01) with serum 25-OHD in the inactive cirrhotics. After an intravenous injection of 120 μg vitamin D3, serum 25-OHD rose significantly within 24 hr in 6 healthy controls and 2 patients with celiac disease but not in 6 inactive cirrhotics. The data suggest impaired 25-hydroxylation of vitamin-D impaired in patients with cirrhosis, related predominantly to the degree of hepatic dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bhattacharya MD, DeLuca HF: The regulation of rat liver calciferol. J Biol Chem 248:2964–2973, 1973

    Google Scholar 

  2. Bhattacharya MD, DeLuca HF: Comparative studies on the 25-hydroxylation of vitamin D3 and dihydrotachysterol. J Biol Chem 248:2974–2977, 1973

    PubMed  Google Scholar 

  3. Norman AW, Midgett RJ, Myrtle JF, Nowicki HG: Studies on calciferol metabolism I. Production of vitamin D metabolite 4B from 25-OH-cholecalciferol by kidney homogenates. Biochem Biophys Res Commun 42:1082–1087, 1971

    PubMed  Google Scholar 

  4. Olson EB, DeLuca HF, 25-hydroxycholecalciferol: Direct effect on calcium transport. Science 165:405–409, 1969

    PubMed  Google Scholar 

  5. Raisz LG, Trummel CL, Simmons H: Induction of bone resorption in tissue culture: Prolonged response after brief exposure to parathyroid hormone of 25-hydroxycholecalciferol. Endocrinology 90:744–751, 1972.

    PubMed  Google Scholar 

  6. Myrtle JF, Haussler MR, Norman AW: Evidence for the biologically active form of cholecalciferol in the intestine. J Biol Chem 245:1190–1196, 1970

    PubMed  Google Scholar 

  7. DeLuca HF: VitaminD-1973. Am J Med 0:1–12, 1974.

    Google Scholar 

  8. Kodicek E: The story of vitamin D: From vitamin to hormone. Lancet 1:325–329, 1974

    PubMed  Google Scholar 

  9. Stanbury SW, Lumb GA, Mawer EB: Osteodystrophy devel oping spontaneously in the course of chronic renal failure. Arch Intern Med 124:274–281, 1969

    PubMed  Google Scholar 

  10. Bour H, Battest J-P, Schaison G: Relexions sur les troubles du metabolisme phosphocalcique dans les cirrhoses. A propos d'un cas avec osteomalacie dominante et de l'exploration de huit autres cirrhotiques. Presse Med 71:2772–2776, 1963

    PubMed  Google Scholar 

  11. Collesson L, Grilliat J-P, Mathieu J: L'osteose rarefiante dans les cirrhoses du foie. Presse Med 73:2571–2574, 1965

    PubMed  Google Scholar 

  12. Meunier P, Dechavanne M, Prost G: L'os des cirrhotiques etudie par lecture quantitative de la biopsie osseuse. Lyon Med 229:1089–1095, 1973

    Google Scholar 

  13. Saville PD: Changes in bone mass with age and alcoholism. J Bone Joint Surg 47A:492–499, 1965

    Google Scholar 

  14. Nillson BE, Westlin NE: Femur density in alcoholism and after gastrectomy. Calcif Tissue Res 10:167–170, 1972

    PubMed  Google Scholar 

  15. Nilsson BE, Westlin NE: Changes in bone mass in alcoholics. Clin Orthop 90:229–232, 1973

    PubMed  Google Scholar 

  16. Chalmers J, Conacher WDH, Gardner DL, Scott PJ: Osteomalacia—a common disease in elderly women. J Bone Joint Surg 49B:403–423, 1967

    Google Scholar 

  17. DeLuca HF: Vitamin D: a new look at an old vitamin. Nutr Rev 29:179–181, 1971

    PubMed  Google Scholar 

  18. Hepner GW, Vesell ES: Quantitative assessment of hepatic function by breath analysis after oral administration of14C-aminopyrine. Ann Intern Med 83:632–638, 1975

    PubMed  Google Scholar 

  19. Belsey R, Deluca HF, Potts JT: Competitive binding assay for vitamin D and 25-OHD vitamin D. J Clin Endocrinol Metab 33:554–557, 1971

    PubMed  Google Scholar 

  20. Rosen JF, Roginsky M, Nathenson G, Finberg L: 25-hydroxyvitamin D plasma levels in mothers and their premature infants with neonatal hypocalcemia. Am J Dis Child 127:220–223, 1974

    PubMed  Google Scholar 

  21. Atkinson M, Nordin BEC, Sherlock S: Malabsorption and bone disease in prolonged obstructive jaundice. Q J Med 25:299–312, 1956

    PubMed  Google Scholar 

  22. Thompson GW, Lewis B, Booth CC: Absorption of vitamin D3 −3H in control subjects and patients with intestinal malabsorption. J Clin Invest 45:94–102, 1966

    PubMed  Google Scholar 

  23. Kehayoglou AK, Agnew JE, Holdsworth CD, Whelton MJ, Sherlock S: Bone disease and calcium absorption in primary biliary cirrhosis. Lancet 1:715–718, 1968

    PubMed  Google Scholar 

  24. Dent CE, Stamp TCB: Theoretical renal phosphorus threshold in investigation and treatment of osteomalacia. Lancet 1:857–860, 1970

    PubMed  Google Scholar 

  25. Stamp TCB: Intestinal absorption of 25-hydroxycholecalciferol. Lancet 2:121–123, 1974

    PubMed  Google Scholar 

  26. Avioli LV, Haddad JG: Vitamin D: Current concepts. Metabolism 22:507–531, 1973

    PubMed  Google Scholar 

  27. Gross JB, Comfort MW, Wollaeger EE, Power MH: Total solids, fat and nitrogen in the feces; study of patients with parenchymatous hepatic disease. Gastroenterology 16:140–150, 1950

    PubMed  Google Scholar 

  28. Fast BB, Wolfe SJ, Stormont JM, Davidson CS: Fat absorption in alcoholics with cirrhosis. Gastroenterology 37:321–324, 1959

    PubMed  Google Scholar 

  29. Rasmussen H, Bordier P: Vitamin D—biochemistry and physiology. The Physiological and Cellular Basis of Metabolic Bone Disease. H Rasmussen, P Bordier (eds). Baltimore, Williams and Wilkins, 1974, pp 207–249

    Google Scholar 

  30. Arnaud SB, Goldsmith RS, Lambert P, Go VLW: 25-hydroxyvitamin D3: Evidence of an enterohepatic circulation in man. Proc Soc Exp Biol Med 149:570–572, 1975

    PubMed  Google Scholar 

  31. Hepner GW: Increased sensitivity of the cholylglycine breath test for detecting ileal dysfunction. Gastroenterology 68:8–16, 1975

    PubMed  Google Scholar 

  32. Hahn TJ, Birge SJ, Scharp CR, Avioli LV: Phenobarbitalinduced alterations in vitamin D metabolism. J Clin Invest 51:741–748, 1972

    PubMed  Google Scholar 

  33. Hahn TJ, Hendin BA, Scharp CR, Haddad JG: Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med 287:900–904, 1972

    PubMed  Google Scholar 

  34. Hahn TJ, Hendin BA, Scharp CR, Boisseau VC, Haddad JG: Serum 25-hydroxycalciferol and bone mass in children anticonvulsants. N Engl J Med 292:550–554, 1975

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by Grant AM 17303 from the National Institutes of Health.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hepner, G.W., Roginsky, M. & Moo, H.F. Abnormal vitamin D metabolism in patients with cirrhosis. Digest Dis Sci 21, 527–532 (1976). https://doi.org/10.1007/BF01464758

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01464758

Keywords

Navigation